AKA vs BABA

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a lack of Altman Z-Score raises concerns about bankruptcy risk assessment. Despite a low Price/Sales ratio of 0.22 suggesting potential undervaluation, the company is unprofitable with negative earnings, declining revenue, and deteriorating ROE of -21.29%. Insider selling, a bearish technical trend, and deeply negative long-term price performance (-89.8% over 5Y) further undermine confidence. While analysts recommend a 'buy' with a $19.75 target, the fundamental and cash flow weaknesses present substantial risks.

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.